In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...

For decades, treatments for macular degeneration have focused on slowing, not restoring vision loss. A new retinal implant is flipping that script, turning patients with geographic atrophy into ...

A unique oral drug candidate that is shown to restore vision and regenerate the retina in an animal model, addressing a major unmet need in ocular therapeutics MIAMI, FLORIDA / ACCESS Newswire / May ...

A groundbreaking retinal implant, PRIMA, is restoring central vision in patients with geographic atrophy (GA), an advanced form of macular degeneration that blinds roughly 1 million Americans. Unlike ...

FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related ...

For individuals with inherited eye disorders such as retinitis pigmentosa or macular degeneration, the irreversible degeneration of the retina—a layer of photoreceptors at the back of the eye—can ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The top retina articles on Healio this year included ...

PARIS, Jan. 14, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, ...